Quick Take Asia

Asia Market Quick Take – 20 November, 2026

Macro 6 minutes to read

Key points:

  • Macro: Trump’s Xi/Putin meetings; no concrete outcomes, energy pledge fell flat
  • Equities: Anthropic (ANT) Nasdaq debut: record $107.3bn IPO; closes +17%
  • FX: USD broadly stronger; USDCNH near 6.70 as yuan weakens 0.4% to one-month low
  • Commodities: Gold heads for biggest weekly drop since March, >7%
  • Fixed income: 10Y yield on track to match 2007 record: 29 closes above 5% this year

------------------------------------------------------------------

Screenshot 2026-11-20 092643

Disclaimer: Past performance does not indicate future performance.

  

Macro:

  • Trump’s warm Xi/Putin meetings spooked allies with fears of Ukraine/Taiwan carve‑ups; no actionable plan emerged as energy pledges fell flat and outcomes were vague (UN reform, ICC, nukes).
  • The Philadelphia Fed manufacturing index fell sharply to 6.3 in November, well below the consensus estimate of 20.1 and down from 20.9 in October — a six-month low. New orders slipped into contraction at -0.4, though shipments rose to 25.7. Prices paid surged to 58.2 from 43.2, adding to inflation concerns.
  • Initial claims rose 1k to 203k, above the 198k consensus estimate. Continuing claims surged 70k to 1.763 million in the week ending Nov. 7.
  • Year-end risk appetite is deteriorating. Traders are increasingly pricing rates staying elevated well into 2027–2028, with money markets now pricing at least two additional Fed hikes by mid-2027.

 

Equities: 

  • US —S&P 500 fell 2.0% to 7,175.83, the Dow Jones shed 2.2% to 49,097.06, and the Nasdaq Composite dropped 2.3% to 23,879.20. Anthropic (ANT) debuted on Nasdaq — the largest IPO on record at $107.3bn — closing 17% above its $83 IPO price at $97.17, but failed to lift broader sentiment. AMD sank on a Hunterbrook Capital short-call citing China risks; AMD denied wrongdoing. Walmart fell 1% despite topping earnings estimates and raised its full year outlook. Williams-Sonoma was the S&P 500's largest single-stock decliner, falling 15.2%. In after-hours trading, Apple says it is developing its own autonomous AI agent rivaling Meta and Anthropic. Meta and Anthropic fell. Intuit dropped ~10% after cutting its full-year revenue forecast and announcing the sale of Mailchimp to Bending Spoons for $3.7bn. Ross Stores fell ~9% after hours on weak Q4 EPS guidance.
  • EU — European equities fell for a fourth consecutive session — the longest losing streak since August — weighed by defensive sectors and geopolitical headwinds. The Stoxx 600 declined 0.9% to 638.41, its lowest close since Oct. 23. The DAX fell 1.1% to 25,463.81 (fifth straight down day), the FTSE 100 dropped 0.9% to 10,452.68, and the CAC 40 lost 0.8% to 8,080.74. Novartis was the largest drag on the Stoxx 600 and SMI, falling 3.2%. Evonik Industries had the largest single-stock decline in the Stoxx 600, dropping 16.2%. AstraZeneca led the FTSE 100 lower, down 2.5%, while Investec was the index's biggest faller at -8.3%. Putin's dismissal of ceasefire talks added further pressure on European assets.
  • Asia — Asian markets are selling off sharply at the open on Friday, tracking Wall Street's sixth consecutive decline and the unravelling of the AI trade. The MSCI Asia Pacific index fell 1.1% to 239.79, extending its losing streak to a seventh straight session. The Kospi opened 4.1% lower at 4,928.51, with chipmaker stocks leading the decline amid heavy foreign selling — foreign funds sold a net $466.1mn of Korean equities on Thursday. The Nikkei 225 (59,444.21) and Hang Seng (22,841.62) are yet to open as of print time, with futures pointing to a weak session. Alibaba tops revenue estimates on AI cloud growth, bringing in 271.5b yuan vs 269.81b yuan est but misses earnings estimates on higher capex; Japan faces additional selling pressure as Monday is a local holiday. The STI (5,079.49) is also yet to open. Anthropic fell in after-hours trading after its debut-day surge, adding to negative sentiment across the region. NetEase's US-listed ADRs fell 9.2% on Thursday after Q3 earnings missed estimates.

Earnings this week:

  • Friday - Dell Technologies, Deere

FX:

  • The yen was the best-performing G10 currency on Thursday, strengthening modestly by 0.16% against the dollar. However, the pair remains elevated near the 160 level that prompted verbal warnings from Japanese Finance Minister Katayama earlier this month.
  • The offshore yuan weakened 0.4% to its lowest level in over a month as the dollar rallied on fading risk appetite. Traders are watching Friday's PBOC fixing closely — the daily fix has been on a 6.71 handle throughout November; any higher print would signal deliberate renminbi weakening.
  • The Australian dollar remains under pressure, having breached support at this year's low. Near-term risks are skewed to the downside, with resistance above 0.68 expected to cap any recovery.
  • Emerging market currencies posted losses for a second consecutive session, with carry-trade favourites such as the Colombian peso and Hungarian forint leading declines as traders continued to price in further US rate hikes. The MSCI EM currency index dipped as much as 0.2%.

Commodities:

  • Gold fell toward its biggest weekly drop since March, down over 7% after a 1% slide Friday to near $3,590/oz (lowest since Sep 2025), as a hawkish Fed and an AI-led selloff spurred liquidation; silver is down about 13% this week.
  • Oil prices have retreated significantly from September highs, with Bloomberg's Commodity Index down 13% from its peak, as a lull in US-Iran hostilities allowed some traffic through the Strait of Hormuz. Supply disruptions remain a risk, but near-term demand concerns tied to the AI trade unwind and broader risk-off sentiment are weighing on prices.

Fixed income:

  • The 10-year yield is on course to match its 2007 record of 29 closes above 5% in a single year, as investors demand compensation for further Fed hikes and resilient US growth. Yields dipped modestly on Thursday as equities sold off sharply, providing a partial safe-haven bid, but the broader trend remains higher.
  • The front end of the curve remains elevated, reflecting market pricing of at least two additional 25bp Fed hikes by mid-2027, with a small probability of a 50bp move in December. The 2s10s spread sits at approximately +28bp, with the curve in a modest bear-steepening configuration as long-end yields hold above 5%.
  • Long-end yields remain elevated, with the 30-year above 5.4%. Wednesday's $16bn 20-year auction was solid, stopping on the screws and providing a brief anchor for the long end. Fidelity International has cautioned that even a 6% 10-year yield would not make Treasuries "massively cheap," while M&G Investments views current levels as a buy given positive real yields north of 2%.

 

For a global look at markets – go to Inspiration.

 

This content is marketing content and should not be considered investment advice. Trading financial instruments carries risks and historic performance is not a guarantee for future performance.
The instrument(s) mentioned in this content may be issued by a partner, from which Saxo receives promotion, payment or retrocessions. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.